Chemotherapy, AdjuvantChemoradiotherapyAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyChemoradiotherapy, AdjuvantRadiotherapy, AdjuvantAdjuvants, ImmunologicFluorouracilNeoplasm StagingCisplatinTreatment OutcomeDisease-Free SurvivalNeoadjuvant TherapyBreast NeoplasmsSurvival AnalysisNeoplasm Recurrence, LocalCyclophosphamideSurvival RatePrognosisAntineoplastic AgentsRectal NeoplasmsFreund's AdjuvantEsophageal NeoplasmsDoxorubicinAntimetabolites, AntineoplasticAdenocarcinomaRadiotherapy DosageCarcinoma, Squamous CellDrug Administration ScheduleLymphatic MetastasisMethotrexateLung NeoplasmsAdjuvants, PharmaceuticTegafurFollow-Up StudiesRadiotherapyKaplan-Meier EstimateHead and Neck NeoplasmsRetrospective StudiesPaclitaxelCarboplatinEsophagectomyDeoxycytidineTaxoidsEpirubicinCarcinoma, Non-Small-Cell LungNasopharyngeal NeoplasmsLeucovorinLevamisoleOrganoplatinum CompoundsInduction ChemotherapyRandomized Controlled Trials as TopicTime FactorsGastrectomyTamoxifenColonic NeoplasmsAnthracyclinesStomach NeoplasmsVinblastineOxonic AcidMastectomyClinical Trials as TopicNeoplasm MetastasisDose FractionationEtoposideTumor Markers, BiologicalProspective StudiesPneumonectomyLymph Node ExcisionProportional Hazards ModelsCystectomyMultivariate AnalysisAntineoplastic Agents, AlkylatingAntineoplastic Agents, HormonalColorectal NeoplasmsPancreatic NeoplasmsDigestive System Surgical ProceduresCarcinomaMitomycinSarcomaMucositisReceptors, EstrogenLymph NodesUracilIfosfamidePreoperative CareFeasibility StudiesHypopharyngeal NeoplasmsLomustineClinical Trials, Phase III as TopicRecurrenceReceptor, erbB-2Salvage TherapyPredictive Value of TestsPremenopauseBrain NeoplasmsOrgan Sparing TreatmentsPostoperative CarePositron-Emission TomographyMedical Oncology